BG Bunge Global
too hard · 36
Owner-earnings value$84.51
Price$112.61
Margin of safety
-25.0%
Quality gate · 36/100
⚠ over-levered (net debt/EBITDA 4.7x > 4x)
Median ROIC11.2%
Gross margin4.9%
Net debt / EBITDA4.7x
FCF conversion-74%
Share count / yr+8.9%
Profitable years4/4
Moat & management
Owner-earnings inputs
| Owner earnings (TTM) | 1.01B |
| Owner-earnings yield | 4.7% |
| Free-cash-flow yield | -3.3% |
| Growth used (normalized) | 1.5% |
| Market-implied growth (reverse DCF) | 8.4% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 9.0% |
Projected owner earnings
| Yr | Owner earnings | Growth | PV |
|---|---|---|---|
| 1 | 1.02B | 1.5% | 937.83M |
| 2 | 1.04B | 1.7% | 874.83M |
| 3 | 1.06B | 1.8% | 817.39M |
| 4 | 1.08B | 2.0% | 764.96M |
| 5 | 1.10B | 2.2% | 717.05M |
| 6 | 1.13B | 2.3% | 673.23M |
| 7 | 1.16B | 2.5% | 633.11M |
| 8 | 1.19B | 2.7% | 596.34M |
| 9 | 1.22B | 2.8% | 562.61M |
| 10 | 1.26B | 3.0% | 531.64M |
Recent news
score · 8 articles
- 3 Reasons BG is Risky and 1 Stock to Buy Instead
- Bunge Lifts 2026 EPS Outlook as Oilseed Momentum Offsets Grain Risks
- Is Bunge Worth Buying as Oilseed Strength Meets Integration Risks?
- Intel Upgraded, CVS Health Downgraded: Updated Rankings on Top Blue-Chip Stocks
- Bunge Global and Nature's Sunshine Shares Are Falling, What You Need To Know
- US Equity Markets End Lower as Oil, Bond Yields Rise After US Strikes on Iran
- Why Bunge Global (BG) Stock Is Up Today
- Zacks Industry Outlook Highlights Bunge Global and GrowGeneration
⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~8%/yr owner-earnings growth over 10y (reverse DCF); model credits 2%.